The European Commission will prioritize the mRNA vaccines (Pfizer, Moderna and CureVac) over the conventional vaccines (AstraZeneca and Johnson & Johnson), in the procurement of vaccines.
The European Commission will prioritize the mRNA vaccines (Pfizer, Moderna and CureVac) over the conventional vaccines (AstraZeneca and Johnson & Johnson), in the procurement of vaccines.
Weekly newsletter on the latest socio-economic and political developments in Denmark and European Union
Contact us: lastweekdk@gmail.com
© Last Week in Denmark | All rights reserved
